Requests the Louisiana Department of Health to update the Medicaid outpatient laboratory fee schedule to cover all CPT codes related to respiratory viral panels.
Impact
If enacted, SR132 would lead to significant changes within Louisiana's Medicaid program regarding coverage for laboratory testing. By updating the fee schedule to incorporate respiratory viral panels, hospitals and healthcare providers would be able to administer these tests without financial burden related to non-reimbursement. This could enhance the overall healthcare delivery and efficiency in diagnosing respiratory illnesses, ultimately improving patient outcomes and potentially limiting the spread of infectious diseases.
Summary
Senate Resolution 132 (SR132), introduced by Senator McMath, calls upon the Louisiana Department of Health to revise its Medicaid outpatient laboratory fee schedule. The resolution specifically requests that all applicable CPT codes concerning respiratory viral panels be included. The aim of this resolution is to ensure that healthcare providers who are part of the Louisiana Medicaid program can receive proper reimbursement for conducting these critical tests, which are essential for timely diagnosis and treatment of respiratory infections.
Sentiment
The general sentiment around SR132 appears to be supportive, particularly among healthcare providers who see the value of including respiratory viral panels in Medicaid coverage. It recognizes the importance of addressing public health concerns, especially following the heightened awareness of respiratory infections due to recent global health events. However, there may also be concerns regarding budget implications for the state Medicaid program and potential opposition from entities wary of increasing expenditures.
Contention
While SR132 presents a proactive approach to healthcare improvement, there might be points of contention regarding its feasibility. Some stakeholders may argue about the potential financial ramifications for taxpayers and the Medicaid budget. Additionally, the resolution's effectiveness will depend on the Department of Health's responsiveness to the requests outlined, including considerations of how quickly they can adapt the fee schedule to reflect the necessity of these tests in a timely manner.
Urges and requests the La. Dept. of Health to increase Medicaid coverage for healthcare services required by individuals with gestational diabetes mellitus
Requires the fee schedule for appropriate current procedural terminology and proprietary laboratory analysis codes be established and regularly updated for all mandatory biomarker precision medical testing coverage by the department of health.
Requires the fee schedule for appropriate current procedural terminology and proprietary laboratory analysis codes be regularly updated for all mandatory biomarker precision medical testing coverage
MEDICAID MANAGED CARE: Requests that the Louisiana Department of Health require the submission of Managed Care Incentive Payment (MCIP) transparency reports
Requests the Louisiana State University School of Health Sciences to conduct certain studies to identify associations between environmental risk factors and maternal health outcomes
Urges and requests the La. Dept. of Health to increase Medicaid coverage for healthcare services required by individuals with gestational diabetes mellitus
Requests the Louisiana Workforce Commission to distribute information regarding the provisions of the Families First Coronavirus Response Act that provides paid sick time to employees who are unable to work due to the effects of COVID-19.